Skip to content

Advertisement

Archived Comments for: Linagliptin: farmacology, efficacy and safety in type 2 diabetes treatment

Back to article

  1. Incorrect spelling in the title

    HARINDRAN NAMASIVAYAM, not applicable

    21 August 2015

    The title should read " Linagliptin: pharmacology.. " not " Linagliptin: farmacology,..."

    Competing interests

    A competing interest exists when your professional judgment about a paper could possibly be influenced by considerations other than the paper's validity or importance. Detail possible competing interests here...

    No competing interests

Advertisement